U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Hydrocortisone Sodium Succinate Injection
Status: Currently in Shortage
»Date first posted: 03/24/2023
»Therapeutic Categories: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology

Expand all

Hospira, Inc., a Pfizer Company (Reverified 10/28/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Solu-cortef, Injection, 1000 mg/vial (NDC 0009-0005-01) Available
Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01) Limited Availability Limited Supply Available. Next Delivery: March 2025; Estimated Recovery: June 2025 Demand increase for the drug
Solu-cortef, Injection, 100 mg/vial (NDC 0009-0011-04) Available
Solu-Cortef, Injection, 100 mg/vial (NDC 0009-0011-03) Limited Availability Limited Supply Available. Next Delivery: October 2024; Estimated Recovery: December 2024 Other
Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-06) Available
Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05) Available
Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12) Available
Back to Top